Third Market, Six Months
Amai Proteins has secured Israeli Ministry of Health approval for its sweelin® sweet protein, clearing the ingredient for use in more than 25 food and beverage categories in Israel. The decision makes Israel the third market to authorize sweelin® commercially, following FDA GRAS status in the United States and a Singapore Food Agency (SFA) approval for use as a sweetening agent — all within a six-month window in 2026. For food and beverage manufacturers operating in or exporting to Israel, the green light means they can begin formulating and commercializing sweelin®-containing products immediately.
sweelin® is a monellin-based sweet protein produced through precision fermentation, averaging roughly 3,000 times the sweetness of sugar by weight. That potency allows manufacturers to use the ingredient at very low inclusion levels while achieving up to 70% reduction in added sugar or conventional sweeteners. The Israeli ministry's review confirmed the ingredient is safe for its intended use and noted its compatibility with industrial food processing — a critical qualifier for high-throughput beverage, confectionery, and foodservice supply chains.
GLP-1 and Clean-Label Tailwinds
The approval arrives as demand for reduced-sugar, clean-label formulations is reshaping packaged food and beverage development across channels, including convenience retail. Dispensed beverages, packaged functional drinks, and better-for-you snacks are among the fastest-growing inside-sales categories at c-stores, driven in part by consumer interest in products compatible with GLP-1 weight-management therapies. Amai points to published clinical data — described as the first human clinical study on a sweet protein — showing sweelin® does not elevate blood glucose, insulin, or GLP-1 levels, positioning it squarely within that emerging formulation brief.
Dr. Amir Guttman, CEO of Amai Proteins, called the Israeli clearance "an important commercial milestone," noting that sweelin® is the first sweet protein approved in Israel. The company is an Israeli biotech, giving the domestic approval added symbolic weight beyond its commercial significance.
What It Means for Manufacturers
For food and beverage manufacturers supplying the convenience channel, sweelin® represents a precision-fermented alternative to high-intensity artificial sweeteners and bulk-calorie sugar at a time when operators are actively seeking differentiated better-for-you SKUs. The ingredient's published stability and industrial processing compatibility suggest it can slot into existing production infrastructure without significant reformulation overhead — an important practical consideration for co-manufacturers and private-label suppliers serving c-store chains.
With three regulatory jurisdictions now cleared, Amai is actively working with manufacturer partners toward commercialization. The pace of approvals — U.S., Singapore, and Israel inside six months — signals the company is moving on a coordinated global launch timeline rather than a market-by-market rollout. Operators and buyers sourcing reduced-sugar beverages and better-for-you snack and beverage innovations should expect sweelin®-enabled SKUs to appear in supplier pitch decks in the near term. Category managers tracking dispensed-beverage and packaged-drink trends may want to monitor which beverage partners are first to market with the ingredient.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
